Inspyr (Formerly Known As GenSpera)
2511 N Loop 1604 W
Suite 204 (3rd Floor)
Inspyr Therapeutics is a biotechnology company focused on the development and commercialization of promising, new therapeutics. Our work is motivated by a commitment to innovation and helping patients. We combine our powerful insights and rigorous scientific methods to create new treatment options for patients.
CEO: Christopher Lowe
COO: Russell B. Richerson
CMO, SVP: Dr. Ronald L. Shazer
Interim Chairman: Peter E. Grebow
Please click here for clinical trial information.